SEARCH OUR PRODUCT CATALOG

AIM1-MYB Fusion FISH Probe

The AIM1-MYB Fusion FISH Probe is used to confirm a fusion of the AIM1 and MYB genes. The fusion of the AIM1 and MYB genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.

** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.

Turnaround Time: 7-10 Business Days    Shipping Time: 1-2 Day Expedited Shipping

SKU Test Kits Buffer Dye Color Order Now
AIM1-MYB-20-ORGR  (Standard Design) 20 (40 μL) 200 μL
AIM1-MYB-20-RERE 20 (40 μL) 200 μL
AIM1-MYB-20-REOR 20 (40 μL) 200 μL
AIM1-MYB-20-REGO 20 (40 μL) 200 μL
AIM1-MYB-20-REGR 20 (40 μL) 200 μL
AIM1-MYB-20-REAQ 20 (40 μL) 200 μL
AIM1-MYB-20-ORRE 20 (40 μL) 200 μL
AIM1-MYB-20-OROR 20 (40 μL) 200 μL
AIM1-MYB-20-ORGO 20 (40 μL) 200 μL
AIM1-MYB-20-ORAQ 20 (40 μL) 200 μL
AIM1-MYB-20-GORE 20 (40 μL) 200 μL
AIM1-MYB-20-GOOR 20 (40 μL) 200 μL
AIM1-MYB-20-GOGO 20 (40 μL) 200 μL
AIM1-MYB-20-GOGR 20 (40 μL) 200 μL
AIM1-MYB-20-GOAQ 20 (40 μL) 200 μL
AIM1-MYB-20-GRRE 20 (40 μL) 200 μL
AIM1-MYB-20-GROR 20 (40 μL) 200 μL
AIM1-MYB-20-GRGO 20 (40 μL) 200 μL
AIM1-MYB-20-GRGR 20 (40 μL) 200 μL
AIM1-MYB-20-GRAQ 20 (40 μL) 200 μL
AIM1-MYB-20-AQRE 20 (40 μL) 200 μL
AIM1-MYB-20-AQOR 20 (40 μL) 200 μL
AIM1-MYB-20-AQGO 20 (40 μL) 200 μL
AIM1-MYB-20-AQGR 20 (40 μL) 200 μL
AIM1-MYB-20-AQAQ 20 (40 μL) 200 μL

MYB Gene Summary

This gene encodes a protein with three HTH DNA-binding domains that functions as a transcription regulator. This protein plays an essential role in the regulation of hematopoiesis. This gene may be aberrently expressed or rearranged or undergo translocation in leukemias and lymphomas, and is considered to be an oncogene. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]

Gene Name: MYB Proto-oncogene, Transcription Factor

Chromosome: CHR6: 135502452 -135540311

Locus: 6q23.3

Gene Diseases

The AIM1 MYB Fusion has been associated with the following diseases:

Disease Name
Breast Invasive Carcinoma

FISH Probe Protocols

Protocol, Procedure, or Form Name Last Modified Download

Genetic rearrangements, hotspot mutations, and microRNA expression in the progression of metastatic adenoid cystic carcinoma of the salivary gland

Adenoid cystic carcinoma (ACC) is a common salivary gland malignancy. The malignancy is associated with gene fusions between MYB, MYBL1, and NFIB. FISH analysis was used to evaluate any rearrangements in these genes with the use of our break apart probes. It was found through FISH that MYB aberrations were preserved between primary tumors and metastases. Additionally, MYB and NFIB aberrations are preserved in ACC metastatic lesions.

Consistent LEF-1 and MYB Immunohistochemical Expression in Human Papillomavirus-Related Multiphenotypic Sinonasal Carcinoma: A Potential Diagnostic Pitfall

HPV-related multiphenotypic sinonasal carcinoma (HMSC) is a sinonasal tract neoplasm with a salivary gland tumor-like appearance. The morphologic profile of HMSC is still not fully understood and is under study. One aspect of this morphologic study included FISH analysis with our MYB break apart probes. No rearrangements in MYB were detected by FISH in the cases under study. It was concluded that MYB protein cannot be used to separate adenoid cystic carcinoma from HMSC.

Human Papillomavirus-Related Multiphenotypic Sinonasal Carcinoma: A Case Report Documenting the Potential for Very Late Tumor Recurrence

Human papillomavirus (HPV)-related multiphenotypic sinonasal carcinoma (HMSC) is a tumor of the sinonasal tract with a wide morphologic spectrum. A case study of HMSC was under analysis to contribute more information about it to the literature. In addition to other analyses, FISH was done with our MYB break apart probe. It was concluded that HMSC tumors can have a long-term recurrence as well as indolent behavior.

MYB rearrangement and immunohistochemical expression in adenomyoepithelioma of the breast: a comparison with adenoid cystic carcinoma

Adenomyoepithelioma (AME) and adenoid cystic carcinoma (ACC) often occur simultaneously, suggesting that AME may be a related or precursor lesion to ACC. MYB gene rearrangements are frequently reported with ACC. Therefore, the rates of MYB rearrangement were compared between AME and ACC. Translocation of the MYB gene was detected by using FISH analysis with our MYB break apart probe. It was concluded that AMEs do not have MYB gene rearrangement.